ECHA Release: May 2015
Companies must notify Echa, within a year, if they intend to support precursors for certain in situ-generated biocides that are at present not part of the biocidal products review programme.
The notification procedure was set up, following recent agreement by the competent authorities on how in situ-generated biocides should be handled. The European Commission, which published a document on the agreed approach, says it is important for all companies selling precursors for in situ systems, and users of such systems or manufactures of devices, to check if they need to take any action.
Biocidal active substances are called 'in situ generated' if they are generated from another substance (a 'precursor') at the place of use. Until now, active substance evaluation has not consistently covered both the precursors and the generated active substance. To improve consistency in the evaluation, potential risks of both the precursor(s) and the substance it generates will now be evaluated.
To take this change into account, the in situ generated active substances have been redefined to consistently refer to both the substance generated in situ and its precursors presently included in the review programme. This may lead to situations where other precursors that are used by industry are not covered by the review programme. Therefore companies using other precursors are invited to notify ECHA within one year if they wish to have their precursor-active substance system also included in the review programme
Meanwhile, Echa has announced that the latest version of the information submission portal, R4BP, has been launched. The new version, 3.2.2, allows companies to make product authorisation change requests in parallel – which could be useful, for example, to change product classifications to meet the 1 June CLP deadline. It also enhances synchronisation between related applications, says the agency